13F-HR filed by GordonMD Global Investments LP
GordonMD Global Investments LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 13 holding rows worth $139,492,635.
- Accession
- 0000919574-26-001152
- Filer
- CIK 2039349
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 13 entries on the cover page, a total value of $139,492,635 stated on the cover page (in dollars after the unit check, H1), rows summing to $139,492,635 with VALUE read as dollars as filed, 13F file number 028-26511. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 4,391,818 | $41,283,089 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 769,550 | $24,017,656 | dollars as filed | |
| BAUSCH PLUS LOMB CORP | 071705107 | COMMON SHARES | 613,472 | $10,478,102 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 224,135 | $10,433,484 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 23,212 | $7,597,520 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 329,101 | $7,569,323 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 1,330,901 | $7,319,956 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 930,317 | $5,609,812 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 66,680 | $5,459,758 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 54,500 | $5,382,965 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 28,587 | $4,975,281 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 4,121,870 | $4,740,151 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 170,307 | $4,625,538 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-26-001152 | this filing | 2026-02-17 | acceptance time not in the bulk data set |